This is where all my skepticism stems from.
FDA requests more evidence of efficacy.
MSB doesn't provide and gets CRL again.
In this CRL they say they will do another trial in adults to address concerns.
Now they're reapplying after not doing it, again.
I know I'm repeating myself - because some people don't seem to be able to follow.
It's pretty simple.
No point beating a dead horse tho. Time will tell.
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-272
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.09 | $1.03 | $7.869M | 7.571M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16411 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 3952 | 2 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.03 |
Change
-0.040 ( 3.65 %) |
||||
| Open | High | Low | Volume | ||
| $1.07 | $1.08 | $1.03 | 1907057 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| MSB (ASX) Chart |